Pauline Maiello Selected Research

Pauline Maiello Research Topics

Disease

13	Granuloma 10/2022 - 01/2015
12	Tuberculosis (Tuberculoses) 01/2020 - 12/2014
11	Infections 01/2022 - 01/2016
4	Inflammation (Inflammations) 01/2020 - 01/2016
2	Pneumonia (Pneumonitis) 01/2017 - 01/2017
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Pulmonary Tuberculosis 01/2020
1	Reinfection 10/2018
1	Bradycardia 03/2017
1	Hypotension (Low Blood Pressure) 03/2017
1	Influenza in Birds (Avian Flu) 01/2017
1	Cytokine Release Syndrome 01/2017
1	Extensively Drug-Resistant Tuberculosis 12/2014

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 10/2022 - 01/2017
5	CytokinesIBA 01/2020 - 01/2015
4	AntigensIBA 01/2020 - 01/2015
4	Pharmaceutical PreparationsIBA 01/2020 - 12/2014
3	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2015
3	Interleukin-17 (Interleukin 17)IBA 01/2016 - 01/2015
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
2	Granzymes (Granzyme)IBA 01/2020 - 08/2015
2	Linezolid (Zyvox)FDA Link 01/2020 - 12/2014
2	Interleukin-2 (IL2)IBA 01/2016 - 01/2016
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021
1	BCG Vaccine FDA Link 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	AerosolsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 10/2018
1	Xylazine (Xylazin)IBA 03/2017
1	Yohimbine (Yocon)IBA 03/2017
1	Hypnotics and Sedatives (Sedatives)IBA 03/2017
1	atipamezoleIBA 03/2017
1	IntegrinsIBA 01/2017
1	AlbuminsIBA 01/2017
1	Tuberculosis VaccinesIBA 01/2017
1	Integrin alpha4beta1 (VLA-4)IBA 01/2017
1	PeptidomimeticsIBA 01/2017
1	LigandsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Rituximab (Mabthera)FDA Link 01/2016
1	PerforinIBA 08/2015
1	EnzymesIBA 08/2015
1	LipopolysaccharidesIBA 08/2015
1	Therapeutic UsesIBA 12/2014
1	Oxazolidinones (2 Oxazolidone)IBA 12/2014

Therapy/Procedure

1	Therapeutics 01/2020
1	Intravenous Administration 01/2020